|Articles|March 2, 2020
- Pharmaceutical Technology-03-02-2020
- Volume 44
- Issue 3
Double Planetary Mixer
The Double Planetary Mixer from Ross is scalable through 1000-gallon production models and is offered in a sanitary turnkey configuration that features a stainless-steel workbench for the mixer and discharge system.
The Double Planetary Mixer from Ross is scalable through 1000-gallon production models and is offered in a sanitary turnkey configuration that features a stainless-steel workbench for the mixer and discharge system.
The sanitary four-gallon Double Planetary Mixer & Discharge System Model DPM/DS-4S (pictured) includes type 316 stainless steel on the interior and exterior, electropolished to a 150-grit (#4) finish. The mixer’s jacketed mixing vessel and high viscosity blades are equipped to produce thick gels, pastes, putties, and other semi-solids at precise temperatures. The sealed gearbox and stirrer shafts guarantee complete cleanability and eliminate cross-contamination between batches.
Articles in this issue
over 5 years ago
Drug Production Draws Multiple Contendersover 5 years ago
Coronavirus Response: Reaction or New Reality?over 5 years ago
Embracing Change Managementover 5 years ago
Isolator Head for Microbial Air Samplingover 5 years ago
Compressor-Free Plate Sealerover 5 years ago
Double Clamshell Barrel Continuous Processorover 5 years ago
Challenges in Clinical Manufacturing for Topical Drugsover 5 years ago
Stability Testing: The Crucial Development Stepover 5 years ago
Keeping Toxicity to a Minimumover 5 years ago
Noteworthy Historical Cases of Adverse Drug ReactionsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
US and European Pharma Manufacturing Face Diverging Paths to Resilience
4
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One
5
